 |
| China's potential awaits drugmakers | | Rajesh Parekh and Franck Le Deu
February 25, 2008
While some multinational pharmaceutical firms are projecting near-term revenue growth of more than 30 percent a year in China, none has yet captured the market's full potential. | |
|
|
|
|
|
|
 |
